Evidence map›Paper›PMID 42609054›Full record

ArticleMolecular imaging and radionuclide therapy2026

The Role of

Gamze Beydağı, Nalan Alan Selçuk, Kaan Akçay, Ayşegül Görmez, Neşet Köksal, Serkan Çelik, Bala Başak Öven, Levent Kabasakal

Abstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gamze BeydağıYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0001-7187-7203
Nalan Alan SelçukYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-3738-6491
Kaan AkçayYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-7706-6388
Ayşegül GörmezYeditepe University Faculty of Medicine, Department of Radiology, İstanbul, Türkiye.ORCID 0000-0001-5620-2881
Neşet KöksalYeditepe University Faculty of Medicine, Department of Surgery, İstanbul, Türkiye.ORCID 0000-0001-8923-9920
Serkan ÇelikYeditepe University, Faculty of Medicine, Department of Medical Oncology, İstanbul, Türkiye.ORCID 0000-0002-5124-6823
Bala Başak ÖvenYeditepe University, Faculty of Medicine, Department of Medical Oncology, İstanbul, Türkiye.ORCID 0000-0002-9921-4089
Levent Kabasakalİstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-4050-1972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Breast cancer is highly heterogeneous, and certain histopathologic subtypes-particularly invasive lobular carcinoma-exhibit low glucose metabolism that limits Methods: Twenty-nine women with pathologically confirmed breast cancer (mean age 57.7±11.6 years) were prospectively enrolled. Histopathology (available in 24 patients) showed lobular carcinoma in 16, ductal carcinoma in 6, signet ring cell carcinoma in 1, and mucinous carcinoma in 1. All underwent both Results: In 7/29 patients (24.1%), neither Conclusion:

Indexed as

68Ga-FAPi PET/CTbreast cancerinvasive lobular carcinomarestagingstaging

Identifiers

PMID42609054
PMCPMC13640850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.